In the STEMI Door-to-Unload trial, use of Impella missed the mark in patients with anterior MI without cardiogenic shock.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't ...

This screenshot from an Abiomed video demonstrates placement of the Impella 2.5 and Impella CP. Delivered in a minimally invasive way, Impella pumps actively unload the heart, aiding native heart ...

NEW ORLEANS -- Microaxial flow pump circulatory support with the Impella device during percutaneous coronary intervention (PCI) didn't help outcomes for complex patients not in cardiogenic shock, two ...

Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in now. Johnson & Johnson (NYSE:JNJ) announced on March 28 that randomized controlled trial (RCT) data presented at the American ...

The biggest names in cardiology tech gathered in New Orleans for the American College of Cardiology (ACC) Scientific Sessions ...

Indications and Usage IOPIDINE 1% Ophthalmic Solution is indicated to control or prevent post-surgical elevations in IOP that occur in patients after argon laser trabeculoplasty, argon laser iridotomy ...

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary ...

An older man presents with acute coronary syndrome and a large atrial myxoma, complicating diagnosis and guiding decisions on revascularization and surgery.